US$ 20.46
generic glp-1 receptor agonists Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care Manufacturers must adapt to growing
Description
11 (Suppl

In addition, there are multiple other drugs currently under development, including several oral drugs such as Orforglipron from Eli Lilly and Danuglipron from Pfizer, as well as further dual and triple receptor agonists
Fitz-Patrick, J
Another approved use for Victoza is to reduce the risk of major cardiovascular disease, like heart attack or stroke, in adults with type 2 diabetes with known heart disease
